Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2023.155025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Abdullah M Shbeer. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia. Electronic address: ashbeer@jazanu.edu.sa. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 115 Literaturangaben.
Abstract (Originalsprache)
DCs have great promise for cancer immunotherapy and are essential for coordinating immune responses. In the battle against cancer, using DCs' ability to stimulate the immune system and focus it on tumor cells has shown to be a viable tactic. This study offers a thorough summary of recent developments as well as potential future paths for DC-based immunotherapy against cancer. This study reviews the many methods used in DC therapy, such as vaccination and active cellular immunotherapy. The effectiveness and safety of DC-based treatments for metastatic castration-resistant prostate cancer and non-small cell lung cancer are highlighted in these investigations. The findings indicate longer survival times and superior results for particular patient groups. We are aware of the difficulties and restrictions of DC-based immunotherapy, though. These include the immunosuppressive tumor microenvironment, the intricacy of DC production, and the heterogeneity within DC populations. More study and development are needed to overcome these challenges to enhance immunological responses, optimize treatment regimens, and increase scalability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Medicine, Jazan University, Jazan, Saudi Arabia. Electronic address: ashbeer@jazanu.edu.sa.
Zitieren
APA
Shbeer, A. M. (2024). Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.155025
Vancouver
Shbeer AM. Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2023.155025
BibTeX
@article{Shbeer2024,
author = {Shbeer, Abdullah M},
title = {Current state of knowledge and challenges for harnessing the power of dendritic cells in cancer immunotherapy},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2023.155025}
}
EUVIMED